ccx559
chemocentryx
['ccx559 ', '$ccxi', 'chemocentryx']
$ccxi chemocentryx reports safety results available from ongoing phase i trial of orally administered pd-l1 inhibitor ccx559 at the 2022 american society of clinical oncology (asco) annual meeting 
GetOnTrade is a news platform to help you stay up-to-date with the latest stock market news. We are not financial advisor(please do your own due diligence).